Psychiatry and Neurology, Neurology · Livingston, NJ
NPI
1306954730
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
200 S Orange Ave, Ste 200
Livingston, NJ, 07039
Phone (973) 322-7580
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
212 services
Medicare patients, 2024
72
Average age 63
Drug cost, 2024
$121K
268 prescriptions
Company payments, 2025
$1,133
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rina Goldberg was code 95720 (neurologic), 86 times for 48 patients. In total Rina Goldberg billed 212 services in 18 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-08-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95720 Neurologic | Facility | 86 | 48 | $179.16 | $15K |
| 99233 Hospital E&M - Subsequent | Facility | 55 | 27 | $102.75 | $5,651 |
| 99232 Hospital E&M - Subsequent | Facility | 20 | 14 | $68.36 | $1,367 |
By year: 2023 $26K for 211 services; 2024 $28K for 212 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rina Goldberg prescribed most often to Medicare patients was Levetiracetam, with 25 prescriptions and refills. In total Rina Goldberg wrote 268 Medicare prescriptions that cost $121K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 25 | 64 | Under 11 | $1,352 |
| Water Water For Irrigation,sterile | 24 | 24 | Under 11 | $6,595 |
| Lacosamide Generic | 24 | 27 | Under 11 | $11K |
| Lamotrigine Generic | 23 | 39 | Under 11 | $2,017 |
| Clonazepam Generic | 17 | 17 | Under 11 | $291 |
| Gabapentin Generic | 15 | 23 | Under 11 | $203 |
| Rufinamide Generic | 12 | 12 | Under 11 | $19K |
| Valtoco Diazepam | 11 | 11 | Under 11 | $10K |
Brand drugs: - claims; generic drugs: 194 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rina Goldberg $1,133 ($1,133 in general payments such as food, travel and fees) from 20 companies. The largest payer was Neurelis, Inc. with $156.
| Company | Payments | Amount |
|---|---|---|
| Neurelis, Inc. | 13 | $156 |
| UCB, Inc. UCB.BR | 9 | $145 |
| Aucta Pharmaceuticals, Inc. | 9 | $110 |
| Abbvie Inc. ABBV | 6 | $99.52 |
| Otter Pharmaceuticals, LLC | 5 | $80.42 |
| SK Life Science, Inc. | 4 | $79.87 |
| ACADIA Pharmaceuticals Inc ACAD | 4 | $67.9 |
| Collegium Pharmaceutical, Inc. COLL | 4 | $63.27 |
| Catalyst Pharmaceuticals, Inc. CPRX | 3 | $51.42 |
| Supernus Pharmaceuticals, Inc. SUPN | 3 | $44.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.